Issue Price
₹101
Per Share
GMP
NIL
Grey Market
Est. Listing
₹101
Expected Price
Min. Application
₹242,400
2 lots × 1200 shares
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.Trident Lifeline Limited offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan licence.Trident Lifeline product portfolio consists of 832 products, as on May 31, 2022, including Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steroidal anti-inflammatory drug (NSAIDs).Trident Lifeline core business categories:1. Ethical marketing of pharmaceutical formulation & products in the International Market through a third-party distribution network and sales force under its brand.2. Getting the approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic as well as International Market.The company operate in India as well as African, Latin American and East Indian Countries. The company have a presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venuzela.
Trident Lifeline Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 175,200 | — | ₹1.77 Cr | — |
| TOTAL | 3,499,200 | 100.00% | ₹35.34 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹121,200 |
| Retail (Max) | 13 | 15,600 | ₹1,575,600 |
| sNII (Min) | 14 | 16,800 | ₹1,696,800 |
| bNII (Min) | 68 | 81,600 | ₹8,241,600 |
| Particulars | 31-Mar-20 | 31-Mar-21 | 31-Mar-22 |
|---|---|---|---|
| Revenue from Operations | 500.71 | 978.13 | 2237.14 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | -79.63 | 63.23 | 227.32 |
| Net Worth | -300.03 | -47.07 | 480.25 |
| Total Assets | 638.92 | 1144.41 | 1385.98 |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |